References
- Mitsumoto H, Pioro EP. Amyotrophic lateral sclerosis. Philadelphia, PA: F.A.D. Company, Editor; 1998.
- Mehta P, Raymond J, Punjani R, Han M, Larson T, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:108–16.
- Aggarwal A. Shashiraj. Juvenile amyotrophic lateral sclerosis. Indian J Pediatr. 2006;73:225–6.
- UPH Service. ALS Registry Act 110th Congress. Public Law. Washington, DC; 2008. 110–373.
- Mehta P. Prevalence of amyotrophic lateral sclerosis - United States, 2010–2011. MMWR Suppl. 2014;63:1–14.
- Mehta P, et al. A revision to the United States national ALS registry’s algorithm to improve case-ascertainment. Amyotroph Lateral Scler Frontotemporal Degener. 2022;24:1–7.
- Picher-Martel V, Brunet F, Dupré N, Chrestian N. The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature. J Child Neurol. 2020;35:556–62.
- Oliveira Santos M, Gromicho M, Pinto S, De Carvalho M. Clinical characteristics in young-adult ALS - results from a Portuguese cohort study. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:620–3.
- Lehky T, Grunseich C. Juvenile amyotrophic lateral sclerosis: a review. Genes (Basel) 2021;12:1935.
- Chen L. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Rev Neurol (Paris). 2021;177:333–40.